How many studies have been conducted on Riluzole?

BiohacksAI has indexed 298 PubMed studies on Riluzole, including 28 randomized controlled trials (RCTs). 57% of studies involve human subjects.

What are the main research areas for Riluzole?

The primary research domains for Riluzole are 🧠 Neuroprotection, 🔬 Oncology, 🧘 Stress & Anxiety. This is based on analysis of 298 PubMed studies using the BiohacksAI evidence platform.

Riluzole

A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

298+ PubMed studies analyzed · 28 RCTs · Evidence Score: 51.2

Research Domains

Riluzole has been studied across 22 research domains including 🧠 Neuroprotection, 🔬 Oncology, 🧘 Stress & Anxiety, 🌤️ Mood & Depression, 🫁 Liver & Detox. The primary research focus is 🧠 Neuroprotection with 52% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Riluzole, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

2-Acetylaminofluorene

Loading evidence profile...

This evidence profile for Riluzole is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.